42 results
8-K
EX-10.1
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
Adverse Effect.
(y) Environmental Laws. The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below … ), (B) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
8-K
EX-10.2
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(y) Environmental Laws. The Company and its Subsidiaries … (A) are in compliance with any and all Environmental Laws (as defined below), (B) have received all permits, licenses or other approvals required of them
D
MYMD
MyMD Pharmaceuticals Inc
30 Aug 22
$7.41M in options / securities to be acquired, 8 investors
8:00am
; Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other
S-4/A
514w15m n9
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
S-4/A
EX-10.48
gcqw3xg
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
S-4
259lqbli0r
15 Jan 21
Registration of securities issued in business combination transactions
5:24pm
D
3ry4q6kz2 ka9v1e
24 Nov 20
$18.07M in equity / securities to be acquired, sold $18.07M, 56 investors
4:21pm
8-K
EX-2.1
ulv hmp5m7
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
8-K
EX-10.3
p2mp umgns4h9q
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
8-K
EX-10.1
jm4zb2ui7s0mh3
13 Aug 20
Entry into a Material Definitive Agreement
8:45am
D
lfh4d12 vo45mwch
11 Aug 20
$0 in equity, 1 investor
3:49pm
D
z6cw9e
21 May 20
$482.5K in options / securities to be acquired, sold $482.5K, 4 investors
3:01pm